SCOPUS 정보 검색 플랫폼

Thrombosis Research

Volumn 130, Issue SUPPL.1, 2012, Pages

Antithrombotic treatment of atrial fibrillation: New insights

(1) Le Heuzey, J Y a

a HÔPITAL EUROPÉEN GEORGES POMPIDOU (France)

Author keywords

Apixaban; Atrial fibrillation; Dabigatran; Rivaroxaban; vitamin K antagonists

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DYSPEPSIA; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; SCORING SYSTEM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; FACTOR XA; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; KIDNEY; MORPHOLINES; PYRAZOLES; PYRIDONES; RISK ASSESSMENT; RISK FACTORS; STROKE; THIOPHENES; TREATMENT OUTCOME; VITAMIN K;

EID: 84867017516 PISSN: 00493848 EISSN: 18792472 Source Type: Journal
DOI: 10.1016/j.thromres.2012.08.277 Document Type: Article

Times cited : (10)

References (10)

1
- 79952902268
- Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of french hospitalisation data
- A. Charlemagne, J. Blacher, A. Cohen, J.P. Collet, F. Dievart, and P. De Groote Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of french hospitalisation data Arch Cardiovasc Dis 104 2011 115 124
- (2011) Arch Cardiovasc Dis , vol.104 , pp. 115-124
- Charlemagne, A.¹ Blacher, J.² Cohen, A.³ Collet, J.P.⁴ Dievart, F.⁵ De Groote, P.⁶

2
- 0348047552
- Cost of Care distribution in Atrial Fibrillation patients: The COCAF study
- J.Y. Le Heuzey, O. Paziaud, O. Piot, M. Ait Said, X. Copie, and T. Lavergne Cost Of Care distribution in Atrial Fibrillation patients: the COCAF study Am Heart J 147 2004 121 126
- (2004) Am Heart J , vol.147 , pp. 121-126
- Le Heuzey, J.Y.¹ Paziaud, O.² Piot, O.³ Ait Said, M.⁴ Copie, X.⁵ Lavergne, T.⁶

3
- 0033527355
- Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
- R.G. Hart, O. Benavente, R. McBride, and L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
- (1999) Ann Intern Med , vol.131 , pp. 492-501
- Hart, R.G.¹ Benavente, O.² McBride, R.³ Pearce, L.A.⁴

4
- 0035854054
- Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
- B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
- (2001) JAMA , vol.285 , pp. 2864-2870
- Gage, B.F.¹ Waterman, A.D.² Shannon, W.³ Boechler, M.⁴ Rich, M.W.⁵ Radford, M.J.⁶

5
- 35148837212
- Increased mortality in paroxysmal atrial fibrillation: Report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
- L. Friberg, N. Hammar, H. Pettersson, and M. Rosenqvist Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF) Eur Heart J 28 2007 2346 2353
- (2007) Eur Heart J , vol.28 , pp. 2346-2353
- Friberg, L.¹ Hammar, N.² Pettersson, H.³ Rosenqvist, M.⁴

6
- 77957699729
- Lip Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- A.J. Camm, P. Kirchhof, U. Schotten, I Savelieva, and S. Ernst Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
- (2010) Eur Heart J , vol.31 , pp. 2369-2429
- Camm, A.J.¹ Kirchhof, P.² Schotten, U.³ Savelieva, I.⁴ Ernst, S.⁵

7
- 70349306707
- Dabigatran versus Warfarin in patients with atrial fibrillation
- S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus Warfarin in patients with atrial fibrillation N Engl J Med 17 2009 1139 1151
- (2009) N Engl J Med , vol.17 , pp. 1139-1151
- Connolly, S.J.¹ Ezekowitz, M.D.² Yusuf, S.³ Eikelboom, J.⁴ Oldgren, J.⁵ Parekh, A.⁶

8
- 80052592404
- Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation
- M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, and W. Hacke Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
- (2011) N Engl J Med , vol.365 , pp. 883-891
- Patel, M.R.¹ Mahaffey, K.W.² Garg, J.³ Pan, G.⁴ Singer, D.E.⁵ Hacke, W.⁶

9
- 79952301326
- AVERROES committees and investigators. Apixaban in patients with atrial fibrillation
- S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, and S. Golitsyn AVERROES committees and investigators. Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
- (2011) N Engl J Med , vol.364 , pp. 806-817
- Connolly, S.J.¹ Eikelboom, J.² Joyner, C.³ Diener, H.C.⁴ Hart, R.⁵ Golitsyn, S.⁶

10
- 80052825103
- ARISTOTLE committees and investigators Apixaban versus Warfarin in patients with atrial fibrillation
- C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, and M. Hanna ARISTOTLE committees and investigators Apixaban versus Warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
- (2011) N Engl J Med , vol.365 , pp. 981-992
- Granger, C.B.¹ Alexander, J.H.² McMurray, J.J.³ Lopes, R.D.⁴ Hylek, E.M.⁵ Hanna, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.